Welcome!

This survey is for the WAIS-5 and WMS-5 Study. This is where you can express interested in taking part for your child, yourself, or a person you are responsible for.

We will first ask you to read the study information. You will then give consent to take part. We will then ask you some basic demographic and health questions. Your answers will help us find out whether you can take part in the study.

It should take about 10 minutes to complete.

If you have questions or want more information, contact the Pearson Clinical Research Team who are conducting this research via phone( +61 3 7065 8533) or email (research@pearson.com.au).
What is this study about?

In this study we will be making Australian and New Zealand versions of three tests:
  • The WAIS-5 is a test of cognitive skills, such as problem solving and paying attention.
  • The WMS-5 is a test of memory and learning.
  • The TFLS-2 is a test practical skills, such as communicating and telling time.
The tests were made in the United States. We need to make sure they give the right results for Australian and New Zealand people. To do this, we need lots of different people to take the tests. This will allow us to understand how people typically do.

Who can take part in the study?

Participants must be aged 16 to 90 years, have English as their primary language, and live in Australia or New Zealand.

We are inviting different groups of people to take part. The groups include:
  • People who have not been diagnosed with any brain-related conditions;
  • People with intellectual disability;
  • People who have been identified as intellectually gifted (based on a standardised cognitive assessment);
  • People living with temporal lobe epilepsy;
  • People who have experienced a traumatic brain injury in the last 6 to 18 months;
  • People who have received a diagnosis of autism spectrum disorder;
  • People who have received a diagnosis of a depression-related disorder;
  • People who have received a diagnosis of schizophrenia; and
  • People who have received a diagnosis of mild Alzheimer’s disease.
Click 'Next' to read what you will do in the study.
 
( Privacy & Cookie Notice

T